SLC22A8 and nonpapillary renal cell carcinoma: In this study, the bioinformatics was used to analyze the expression and epigenetic alterations of SLC22A8 in RCC and its interconnection with immune cells to determine its expression pattern, potential function, and prognostic value in ccRCC, providing new insights into the clinical diagnosis, prognosis, and treatment strategies for patients with ccRCC.